Neuromodulation of Inflammation and Endothelial Function
RecruitingNCT05230732Phase: NAStarted 2022-09-01
Summary
Heart failure with reduced ejection fraction (HFrEF) is a major cause of mortality in United States. Aging is a major risk factor for adverse outcomes associated with HFrEF, with majority of the patie
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
85 Years
Locations
University of Oklahoma Health Sciences CenterOklahoma City, Oklahoma, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT05230732